Filing Details
- Accession Number:
- 0001415889-24-013352
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-16 16:30:26
- Reporting Period:
- 2024-05-15
- Accepted Time:
- 2024-05-16 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636178 | James Edgemond | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Cfo And Treasurer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-05-15 | 25,000 | $163.30 | 26,578 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-15 | 25,000 | $272.69 | 1,578 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-05-15 | 15,160 | $163.30 | 16,738 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-05-15 | 15,160 | $272.69 | 1,578 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Share Tracking Award | Share Tracking Award | Disposition | 2024-05-15 | 25,000 | $0.00 | 25,000 | $163.30 |
| Share Tracking Award | Share Tracking Award | Disposition | 2024-05-15 | 15,160 | $0.00 | 15,160 | $163.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-03-13 | 2025-03-13 | No | 4 | M | Direct |
| 0 | 2016-03-13 | 2025-03-13 | No | 4 | M | Direct |
Footnotes
- Includes 26, 59, 47, and 62 shares of common stock acquired on September 2, 2022, March 3, 3023, September 1, 2023, and March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan.
- Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
Billionaire Hedge Funds
